Testing effectiveness (Phase 2)Study completedNCT00901524
What this trial is testing
ANRS HC20 Effectiveness of an Optimized Anti HCV PegIFN-alpha2a + Ribavirin on Sustained Virological Response in Patients With HCV Genotype 1 and 4 Non Responders and Co-infected With HIV
Who this might be right for
Hepatitis
ANRS, Emerging Infectious Diseases 58